JP2025503400A5 - - Google Patents

Info

Publication number
JP2025503400A5
JP2025503400A5 JP2024534202A JP2024534202A JP2025503400A5 JP 2025503400 A5 JP2025503400 A5 JP 2025503400A5 JP 2024534202 A JP2024534202 A JP 2024534202A JP 2024534202 A JP2024534202 A JP 2024534202A JP 2025503400 A5 JP2025503400 A5 JP 2025503400A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
antibody
sequence shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534202A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025503400A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081297 external-priority patent/WO2023108138A1/en
Publication of JP2025503400A publication Critical patent/JP2025503400A/ja
Publication of JP2025503400A5 publication Critical patent/JP2025503400A5/ja
Pending legal-status Critical Current

Links

JP2024534202A 2021-12-10 2022-12-09 完全イヌ抗イヌｐｄ－１抗体およびその使用 Pending JP2025503400A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163288284P 2021-12-10 2021-12-10
US63/288,284 2021-12-10
PCT/US2022/081297 WO2023108138A1 (en) 2021-12-10 2022-12-09 Fully canine anti-canine pd-1 antibodies and uses thereof

Publications (2)

Publication Number Publication Date
JP2025503400A JP2025503400A (ja) 2025-02-04
JP2025503400A5 true JP2025503400A5 (https=) 2025-12-16

Family

ID=86731339

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024534202A Pending JP2025503400A (ja) 2021-12-10 2022-12-09 完全イヌ抗イヌｐｄ－１抗体およびその使用

Country Status (7)

Country Link
US (1) US20250051447A1 (https=)
EP (1) EP4444754A4 (https=)
JP (1) JP2025503400A (https=)
KR (1) KR20240139600A (https=)
CN (1) CN118922441A (https=)
CA (1) CA3240188A1 (https=)
WO (1) WO2023108138A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025106547A1 (en) * 2023-11-14 2025-05-22 The Trustees Of Dartmouth College Anti-canine pd-1 antibodies, compositions containing, and therapeutic or diagnostic use thereof
WO2025113570A1 (en) * 2023-11-29 2025-06-05 Vetigenics, Inc. Fully canine antibodies and uses thereof
CN120137035A (zh) * 2023-12-06 2025-06-13 北京伟杰信生物科技有限公司 一种抗犬pd-1抗体及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722587B2 (en) * 2008-04-09 2014-05-13 The Trustees Of The University Of Pennsylvania Single chain fragment variable antibody libraries and uses thereof
CN106029697B (zh) * 2013-12-20 2021-06-04 英特维特国际股份有限公司 具有经修饰的ch2-ch3序列的犬抗体
EP3448874A4 (en) * 2016-04-29 2020-04-22 Voyager Therapeutics, Inc. COMPOSITIONS FOR TREATING A DISEASE
SG11202105153RA (en) * 2018-11-19 2021-06-29 Biocytogen Pharmaceuticals Beijing Co Ltd Anti-pd-1 antibodies and uses thereof

Similar Documents

Publication Publication Date Title
JP2025503400A5 (https=)
JP6862435B2 (ja) 抗ｗｔ１／ｈｌａ特異的抗体
CN113677359A (zh) Cd25抗体
JP7778701B2 (ja) 抗ｓｔ２抗体及びその適用
JP2014534218A5 (https=)
JP2020534830A5 (https=)
JP2019516348A (ja) 重症熱性血小板減少症候群ウイルスの外膜糖タンパク質に結合する抗体及びその用途
JP2024105229A5 (https=)
JP2023540526A5 (https=)
JP7851923B2 (ja) インターロイキン１アルファに特異的な真のヒト抗体
WO2022083675A1 (zh) 针对多种冠状病毒的单克隆抗体及应用
JP2021530244A5 (https=)
JP7830445B2 (ja) インターロイキン１アルファに特異的な真のヒト抗体
JP6998470B2 (ja) Ｆｏｌｒ１に特異的に結合する抗体及びその用途
CN116444667B (zh) 一种靶向gdf15的全人源抗体及其应用
JP2024012431A (ja) 抗ｂｃｍａ抗体及びその用途
JP2018528759A5 (https=)
JP2017505758A (ja) 黄色ブドウ球菌のｌｕｋｇｈ（ｌｕｋａｂ）毒素に対する抗体及び抗体配列
JP2025505650A5 (https=)
CN110156895B (zh) 一种抗pd-l1抗体或其功能性片段及其用途
AU2020400801B2 (en) Anti-BCMA/anti-4-1BB bispecific antibodies and uses thereof
JP2020505465A5 (https=)
KR102602564B1 (ko) 인터루킨-6의 인간 수용체에 결합가능한 항체 또는 항원 결합성 단편
CN114891108B (zh) 一种靶向bcma的全人源抗体及其应用
CN121079324A (zh) 抗cntn4抗体及其用途